Aardvark Therapeutics, Inc. (AARD)
NMS · Healthcare · Biotechnology
$3.90
+7.14%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$85.1M
Shares Outstanding
21.8M
Exchange
NMS
Currency
USD
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -15.8M | -17.7M | -18.7M | -22.5M |
| Net Income | -14.4M | -16.3M | -17.6M | -21.6M |
| Diluted EPS | $-0.66 | $-0.75 | $-0.81 | $-0.99 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -10.9M | -6.7M | -22.7M | -62.7M |
| Net Income | -13.6M | -7.2M | -20.6M | -57.6M |
| Diluted EPS | $-1.39 | $-0.56 | $-0.96 | $-2.93 |